![Jared Gollob](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jared Gollob
No más puestos en curso
Fortuna: 8 M $ al 31/08/2026
Perfil
Jared Gollob worked at Duke University from 2002 to 2007 as Director of the Biologic Therapy Program.
From 2007 to 2018, worked at Alnylam Pharmaceuticals, Inc., serving as Global VP of Medical Affairs and Clinical Development from 2012 to 2018.
From 2018 to 2026, worked at Kymera Therapeutics, Inc. as Chief Medical Officer.
Former jobs include Director-Biologic Therapy Program at Duke University and Global VP-Medical Affairs & Clinical Development at Alnylam Pharmaceuticals, Inc.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2026 | 71.359 ( 0,09 % ) | 8 M $ | 31/08/2026 |
Antiguos cargos conocidos de Jared Gollob.
| Empresas | Cargo | Fin |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 27/07/2026 |
| ALNYLAM PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/08/2018 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/09/2007 |
Formación de Jared Gollob.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
91
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
- Bolsa de valores
- Insiders
- Jared Gollob
